19:11 IST
NSE
Other Announcement
Curis Lifesciences Other Announcement
Curis Lifesciences Limited submitted the RTA confirmation certificate for the quarter ended June 30, 2026, as required under SEBI Regulation 74(5).
Curis Lifesciences Ltd
- Share price
- ₹202.00
- Market cap
- ₹163.3 Cr
- Revenue (annual)
- ₹60.63 Cr
- Net profit (annual)
- ₹6.92 Cr
- P/E (TTM)
- 23.6×Sector 47.3×
- Promoter holding
- 68.03%
- FII holding
- 1.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Management Change 3Legal & Regulatory 2Financial Results 2Results Correction 1Merger & Restructuring 1Fund Raise 1Board Meeting Outcome 1Board Meeting Date 1Annual General Meeting 1
Time
5 announcements with these filters
14:27 IST
NSE
Other Announcement
Curis Lifesciences Other Announcement
Curis Lifesciences Limited filed its annual SDD compliance certificate for FY2026. The company confirmed full adherence to SEBI Insider Trading regulations regarding digital databases.
18:19 IST
NSE
Other Announcement
Curis Lifesciences Other Announcement
Curis Lifesciences Limited confirmed its non-applicability as a Large Corporate for FY 2026-27. This regulatory filing clarifies the company is exempt from SEBI debt-raising framework requirements.
17:27 IST
NSE
Other Announcement
Curis Lifesciences Other Announcement
Curis Lifesciences Limited confirmed its non-applicability as a Large Corporate for FY 2026-27. This regulatory filing streamlines compliance requirements for future debt issuances.
13:03 IST
NSE
Other Announcement
Curis Lifesciences Other Announcement
Curis Lifesciences Limited informed the exchange regarding the non-applicability of Corporate Governance and Annual Secretarial Compliance Report requirements for the period ended March 31, 2026. As an NSE SME listed company, it is exempt under Regulation 15(2) of SEBI LODR Regulations, 2015.